Cardiologists
McGill University, Montreal, Qc, Canada
Amgen (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)HLS (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Novartis (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Sanofi (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)
Dr. Thanassoulis is the Director of Preventive and Genomic Cardiology at the MUHC and an Associate Professor of Medicine at McGill University. His clinical interests are in cardiovascular prevention, dyslipidemia (specifically lipoprotein[a]) and premature coronary artery disease. He currently runs the MUHC Family Heart Clinic for patients with premature CAD and their families with the goal of optimizing their preventive care. His research interests are in the genetics of aortic valve stenosis where he leads an international consortium investigating the role of genomic variation in this disease. He is also working on developing new approaches to optimize cardiovascular prevention in young individuals. He is the co-chair of the 2021 CCS Dyslipidemia Guideline Committee.